Treating cancer is a challenging and difficult task, and it’s made all the more difficult when the cancer that you are treating is malignant mesothelioma. One of the rarest of all cancers, this disease is caused by exposure to asbestos and represents just 0.3 percent of all cancers diagnosed in the United States. Treatment options are limited and have not been curative: today’s most successful protocols offer the potential for a better quality of life and longer survival times, but the condition is still considered to be fatal. The dedicated medical professionals who are making advances in the treatment of this disease specialize in the impact of asbestos on the human body.
The victims of asbestos suffer from mesothelioma, asbestosis and other asbestos-related diseases and cancers. Many are entitled to compensation from the asbestos trust funds, which hold over $30 billion in funds dedicated for the purpose of helping pay for medical bills and other expenses. If you or someone you love has been diagnosed with an asbestos-related disease, contact us today to be put in touch with a mesothelioma attorney who can help you file a claim with the asbestos trust funds, or to file a mesothelioma lawsuit against the asbestos companies. We will also send you a free Financial Compensation Packet that contains valuable information on your rights.
Patients who have been diagnosed with mesothelioma need specialized care. Studies have shown that receiving treatment at a hospital or medical school that has a dedicated cancer center – and particularly those that have experience in treating patients with mesothelioma – have longer survival times. Here are some of the top mesothelioma specialists in the United States.
- Robert Cameron, M.D., UCLA Health System, Los Angeles, California
Dr. Cameron is Director of the Comprehensive Mesothelioma Program of the David Geffen School of Medicine at the University of California, Los Angeles and the Ronald Reagan UCLA Medical Center, where he specializes in surgical oncology and thoracic surgery. He is also the chief of thoracic surgery at the West Los Angeles Veteran’s Administration Medical Center. He is certified in surgery by the American Board of Surgery and in thoracic surgery by the American Board of Thoracic Surgery. He graduated from the UCLA School of Medicine in 1984.
- David Sugarbaker, M.D., Baylor College of Medicine, Houston, Texas
Dr. Sugarbaker is Professor and Chief of the Division of General Thoracic Surgery at the Baylor College of Medicine, as well as Director of its Lung Institute and the Olga Keith Wiess Chair in Surgery. He is an internationally recognized thoracic surgeon who specializes in the treatment of mesothelioma. He is board certified in surgery and thoracic surgery. He graduated from the Cornell University Medical College in 1979.
- Hedy Lee Kindler, M.D., The University of Chicago, Chicago, Illinois
Dr. Kindler is a Professor of Medicine, the Medical Director of the department of Gastrointestinal Oncology, and Director of the University of Chicago’s Mesothelioma Program. She specializes in the treatment of malignant mesothelioma and is an active member of several boards and committees dedicated to researching mesothelioma, pancreatic cancer, and other diseases. She has been awarded the Selikoff Lifetime Achievement Award by the Asbestos Disease Awareness Organization. She is a graduate of the State University of New York at Buffalo’s medical school.
- David C. Rice, M.B., B.Ch., B.A.O., F.R.C.S.I., The University of Texas MD Anderson Cancer Center, Houston, Texas
Dr. Rice is a professor of surgery in the Department of Thoracic and Cardiovascular Surgery, Division of Surgery. He is internationally recognized for his research on malignant mesothelioma and lung cancer, while he is also respected for his leadership in the field of thoracic surgery, finding new ways to remove cancers while minimizing pain and trauma for the patient. He received his medical degree at the School of Medicine, Trinity College, the University of Dublin in 1991.
- Lary Allen Robinson, M.D., H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
As director of the HLMCC’s Division of Cardiovascular and Thoracic Surgery, Dr. Robinson has focused on the aggressive surgical treatment of mesothelioma. He has been in practice for over 40 years, and is a member of the Science Advisory Board of the Mesothelioma Applied Research Foundation. He graduated from the Washington University School of Medicine in St. Louis, Missouri.
- Stephen C. Yang, M.D., B.Ch., F.A.C.S., F.A.C.C., Johns Hopkins University School of Medicine, Baltimore, Maryland
Dr. Yang is the Associate Vice Chair for Faculty Development and a professor of surgery with expertise in mesothelioma, pleural diseases, thoracic surgery, and video-assisted thoracic surgery. His research interests include the molecular biology of mesothelioma and the development of molecular markers for early diagnosis of lung cancer and of recurrent lung cancer following surgical resection. He graduated from the medical school of the Virginia Commonwealth University in 1984.
- Michael Slaughter, M.D., St. Francis Cancer Center, Indianapolis, Indiana
Dr. Slaughter is an Internal Medicine Hospitalist and specialist in hematology and oncology. His area of focus is lung cancer, solid tumors and colon and breast cancers, with a special interest in improving the prognosis for patients in all stages of lung and chest cancers, including mesothelioma. He graduated from the Meharry Medical College School of Medicine in 1991.
- Michael J. Liptay, M.D., Rush University Medical Center, Chicago, Illinois
Dr. Liptay is the Chair of Cardiovascular-Thoracic Surgery at Rush University Medical Center and is recognized as a national leader in the development of minimally invasive thoracic surgery. He has a history of active involvement in research in the field of thoracic surgery and has practiced medicine since 1991, specializing in thoracic oncology. He graduated from Northwestern University Medical School and holds leadership roles in many scientific and professional organizations.
Patients who have been diagnosed with mesothelioma and other asbestos-related diseases require the specialized treatment protocols offered by dedicated professionals like the ones listed above. They also may be entitled to compensation from the asbestos companies responsible for exposing them to the carcinogen that caused their illness. For more information on your right and on the compensation to which you may be entitled, call 1-800-706-5606 today to speak with one of our dedicated professionals.